Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s Promotional Assessments Reorganized Around Specialty, Not Target Audience

This article was originally published in The Pink Sheet Daily

Executive Summary

The two divisions within the Office of Prescription Drug Promotion are renamed the divisions of advertising and promotion review I and II; they will each have four teams operating within them in a structure akin to the Office of New Drugs.

You may also be interested in...



FDA Off-Label Citations Disappear In Post-Caronia Enforcement Letters

Office of Prescription Drug Promotion letters post-Caronia fail to cite off-label promotion, in contrast to previous years when about one-third to one-half of warning and untitled letters scolded companies for off-label violations.

DTC Pre-review Requirement Broadly Defined Under FDA Draft Guidance

The agency’s draft guidance on prereview of television advertisements also requires companies to submit the information they rely on to support claims in an ad.

FDA's Drug Advertising Oversight Gets A Promotion From A Division To An Office

The Division of Drug, Advertising, Marketing and Communications will consist of an office with two divisions, one to review materials for healthcare professionals and other to review direct-to-consumer promotions.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS075496

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel